Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Expert Opinion on Investigational Drugs
Volume 33, 2024 - Issue 2
Review
New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology
Xingyu Zhoua Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China;b National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China;c State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China;d Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China
https://orcid.org/0009-0001-0668-455XView further author information
https://orcid.org/0009-0001-0668-455XView further author information, Dong Xua Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China;b National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China;c State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China;d Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, Chinahttps://orcid.org/0000-0002-6413-3043View further author information
https://orcid.org/0000-0002-6413-3043View further author information, Mengtao Lia Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China;b National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China;c State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China;d Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, Chinahttps://orcid.org/0000-0003-4252-2889View further author information
https://orcid.org/0000-0003-4252-2889View further author information & Xiaofeng Zenga Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China;b National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China;c State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China;d Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-3883-2318View further author information
https://orcid.org/0000-0002-3883-2318View further author information